This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Albert Einstein College of Medicine, Northwestern University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 515 
1 out of 2,233 
Years Active: 2015
Title: Thomas S Leyh: Innovator in Fluorinated Prodrug Compounds
Introduction
Thomas S Leyh is a notable inventor based in Katonah, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of fluorinated prodrug compounds.
Latest Patents
Thomas S Leyh holds 1 patent for his work on fluorinated prodrug compounds that can be used for selective streptococcal mevalonate pathway inhibition. This innovative approach has the potential to impact therapeutic strategies against certain bacterial infections.
Career Highlights
Throughout his career, Leyh has been associated with prestigious institutions such as Northwestern University and Albert Einstein College of Medicine. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Leyh has collaborated with notable colleagues, including Richard B Silverman and Mizuki Watanabe. These partnerships have enriched his research and fostered innovation in his field.
Conclusion
Thomas S Leyh's contributions to the development of fluorinated prodrug compounds highlight his role as an important figure in medicinal chemistry. His work continues to influence the landscape of therapeutic research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile